Tandem Diabetes Care (TNDM) Profit After Tax Growth (1y) (2014 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Profit After Tax Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | 18.51% |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | 41.26% |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 13.84% |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | -27.98% |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 12.92% |
| 10 | Tandem Diabetes Care | 1.26 Bn | 808.29 Mn | 144.78 Mn | 59.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.60% |
| Mar 31, 2026 | 83.96% |
| Dec 31, 2025 | -178.01% |
| Sep 30, 2025 | 8.97% |
| Jun 30, 2025 | -68.32% |
| Mar 31, 2025 | -190.00% |
| Dec 31, 2024 | 102.52% |
| Sep 30, 2024 | 31.56% |
| Jun 30, 2024 | 15.57% |
| Mar 31, 2024 | 63.66% |
| Dec 31, 2023 | -89.26% |
| Sep 30, 2023 | 31.71% |
| Jun 30, 2023 | -126.55% |
| Mar 31, 2023 | -621.87% |
| Dec 31, 2022 | -246.67% |
| Sep 30, 2022 | -958.68% |
| Jun 30, 2022 | -506.11% |
| Mar 31, 2022 | -232.69% |
| Dec 31, 2021 | -36.42% |
| Sep 30, 2021 | 161.59% |